Finally, we investigated the consequences of Tspan6 loss in an AD mouse model by crossing Tspan6 KO mice with mice expressing endogenous levels of the human APP gene with the Swedish and Iberian mutations (AppNL/F) that trigger the formation of amyloid plaques [41]. This evidence concerns the gene TSPAN6 and Alzheimer disease.